Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:2016-2022
Published online before print March 29, 2004, doi: 10.1161/01.CIR.0000125527.41598.68
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/16/2016    most recent
01.CIR.0000125527.41598.68v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khreiss, T.
Right arrow Articles by Filep, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khreiss, T.
Right arrow Articles by Filep, J. G.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Acute coronary syndromes
Right arrow Other Vascular biology
Right arrowRelated Article

(Circulation. 2004;109:2016-2022.)
© 2004 American Heart Association, Inc.


Basic Science Reports

Conformational Rearrangement in C-Reactive Protein Is Required for Proinflammatory Actions on Human Endothelial Cells

Tarek Khreiss, MSc; Levente József, MSc; Lawrence A. Potempa, PhD; János G. Filep, MD

From the Research Center, Maisonneuve-Rosemont Hospital and Department of Medicine (T.K., L.J., J.G.F.), University of Montreal, Montreal, QC, Canada, and Immtech International, Inc (L.A.P.), Vernon Hills, Ill.

Correspondence to János G. Filep, MD, Research Center, Maisonneuve-Rosemont Hospital, 5415 boulevard de l’Assomption, Montreal, Quebec, Canada H1T 2M4. E-mail janos.g.filep{at}umontreal.ca

Received July 10, 2003; de novo received October 14, 2003; revision received January 5, 2004; accepted January 12, 2004.

Background— C-reactive protein (CRP) has been suggested to actively amplify the inflammatory response underlying coronary heart diseases by directly activating endothelial cells. In this study, we investigated whether loss of the cyclic pentameric structure of CRP, resulting in formation of modified or monomeric CRP (mCRP), is a prerequisite for endothelial cell activation.

Methods and Results— We examined the impact of native CRP and mCRP on the production of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), key regulators of leukocyte recruitment, and on the expression of intercellular adhesion molecule-1 (ICAM-1), E-selectin, and vascular adhesion molecule-1 (VCAM-1) in human cultured coronary artery endothelial cells (HCAECs). Incubation with mCRP for 4 hours increased MCP-1 and IL-8 secretion and mRNA levels and expression of ICAM-1, E-selectin, and VCAM-1 protein and mRNA. Significant induction occurred at 1 to 5 µg/mL, reached a maximum at 30 µg/mL, and did not require the presence of serum. Native CRP was without detectable effects at 4 hours, whereas it enhanced cytokine release after a 24-hour incubation. An anti-Fc{gamma}RIII (CD16) but not an anti-Fc{gamma}RII (CD32) antibody produced a 14% to 32% reduction of the mCRP effects (P<0.05). mCRP but not CRP evoked phosphorylation of p38 mitogen-activated protein kinase, and inhibition of this kinase with SB 203580 reversed the effects of mCRP. Furthermore, culture of HCAECs in the presence of SB203580 markedly decreased mCRP-stimulated E-selectin and ICAM-1–dependent adhesion of neutrophils to HCAECs (P<0.001).

Conclusions— Loss of pentameric symmetry in CRP, resulting in formation of mCRP, promotes a proinflammatory HCAEC phenotype through a p38 MAPK–dependent mechanism.


Key Words: proteins • cell adhesion molecules • signal transduction • endothelium • inflammation


Related Article:

C-Reactive Protein: Structure Affects Function
Subodh Verma, Paul E. Szmitko, and Edward T.H. Yeh
Circulation 2004 109: 1914-1917. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Clin. Chem.Home page
S. B. Schwedler, T. Hansen-Hagge, M. Reichert, D. Schmiedeke, R. Schneider, J. Galle, L. A. Potempa, C. Wanner, and J. G. Filep
Monomeric C-Reactive Protein Decreases Acetylated LDL Uptake in Human Endothelial Cells
Clin. Chem., September 1, 2009; 55(9): 1728 - 1731.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. G. Filep
Platelets Affect the Structure and Function of C-Reactive Protein
Circ. Res., July 17, 2009; 105(2): 109 - 111.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. U. Eisenhardt, J. Habersberger, A. Murphy, Y.-C. Chen, K. J. Woollard, N. Bassler, H. Qian, C. von zur Muhlen, C. E. Hagemeyer, I. Ahrens, et al.
Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques
Circ. Res., July 17, 2009; 105(2): 128 - 137.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Tanigaki, C. Mineo, I. S. Yuhanna, K. L. Chambliss, M. J. Quon, E. Bonvini, and P. W. Shaul
C-Reactive Protein Inhibits Insulin Activation of Endothelial Nitric Oxide Synthase via the Immunoreceptor Tyrosine-Based Inhibition Motif of Fc{gamma}RIIB and SHIP-1
Circ. Res., June 5, 2009; 104(11): 1275 - 1282.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S.-R. Ji, L. Ma, C.-J. Bai, J.-M. Shi, H.-Y. Li, L. A. Potempa, J. G. Filep, J. Zhao, and Y. Wu
Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains
FASEB J, June 1, 2009; 23(6): 1806 - 1816.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. El Kebir, L. Jozsef, W. Pan, L. Wang, and J. G. Filep
Bacterial DNA Activates Endothelial Cells and Promotes Neutrophil Adherence through TLR9 Signaling
J. Immunol., April 1, 2009; 182(7): 4386 - 4394.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. R.W. Kuhlmann, L. Librizzi, D. Closhen, T. Pflanzner, V. Lessmann, C. U. Pietrzik, M. de Curtis, and H. J. Luhmann
Mechanisms of C-Reactive Protein-Induced Blood-Brain Barrier Disruption * Supplemental Methods
Stroke, April 1, 2009; 40(4): 1458 - 1466.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
B. T. Baune, G. Ponath, M. Rothermundt, A. Roesler, and K. Berger
Association Between Cytokines and Cerebral MRI Changes in the Aging Brain
J Geriatr Psychiatry Neurol, March 1, 2009; 22(1): 23 - 34.
[Abstract] [PDF]


Home page
StrokeHome page
B. T. Baune
The Puzzle of Predicting the Impact of Brain Infarcts on Cognitive Impairment in the Aging Brain
Stroke, March 1, 2009; 40(3): 667 - 669.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Devaraj, U. Singh, and I. Jialal
The Evolving Role of C-Reactive Protein in Atherothrombosis
Clin. Chem., February 1, 2009; 55(2): 229 - 238.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Molins, E. Pena, G. Vilahur, C. Mendieta, M. Slevin, and L. Badimon
C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2239 - 2246.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. Maingrette, L. Li, and G. Renier
C-reactive protein enhances macrophage lipoprotein lipase expression
J. Lipid Res., September 1, 2008; 49(9): 1926 - 1935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Xing, F. G. Hage, Y.-F. Chen, M. A. McCrory, W. Feng, G. A. Skibinski, E. Majid-Hassan, S. Oparil, and A. J. Szalai
Exaggerated Neointima Formation in Human C-Reactive Protein Transgenic Mice Is IgG Fc Receptor Type I (Fc{gamma}RI)-Dependent
Am. J. Pathol., January 1, 2008; 172(1): 22 - 30.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S.-R. Ji, Y. Wu, L. Zhu, L. A. Potempa, F.-L. Sheng, W. Lu, and J. Zhao
Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRPm
FASEB J, January 1, 2007; 21(1): 284 - 294.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Libby and P. M. Ridker
Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A33 - A46.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. N Hanson, H. M Engelman, D L. Alekel, K. L Schalinske, M. L Kohut, and M. B Reddy
Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 774 - 780.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. D. Bushnell, P. Hurn, C. Colton, V. M. Miller, G. del Zoppo, M. S.V. Elkind, B. Stern, D. Herrington, G. Ford-Lynch, P. Gorelick, et al.
Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group
Stroke, September 1, 2006; 37(9): 2387 - 2399.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Zhong, S.-H. Li, S.-M. Liu, P. E. Szmitko, X.-Q. He, P. W.M. Fedak, and S. Verma
C-Reactive Protein Upregulates Receptor for Advanced Glycation End Products Expression in Human Endothelial Cells
Hypertension, September 1, 2006; 48(3): 504 - 511.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Paffen and M. P.M. deMaat
C-reactive protein in atherosclerosis: A causal factor?
Cardiovasc Res, July 1, 2006; 71(1): 30 - 39.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Oroszlan, E. Herczenik, S. Rugonfalvi-Kiss, A. Roos, A. J Nauta, M. R Daha, I. Gombos, I. Karadi, L. Romics, Z. Prohaszka, et al.
Proinflammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modified CRP
Int. Immunol., June 1, 2006; 18(6): 871 - 878.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, I. Jialal, B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, and I. Jialal
The Verdict Is Still Out
Circulation, May 2, 2006; 113(17): 2128 - 2151.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Montero, J. Orbe, N. Varo, O. Beloqui, J. I. Monreal, J. A. Rodriguez, J. Diez, P. Libby, and J. A. Paramo
C-Reactive Protein Induces Matrix Metalloproteinase-1 and -10 in Human Endothelial Cells: Implications for Clinical and Subclinical Atherosclerosis
J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1369 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S.-R. Ji, Y. Wu, L. A. Potempa, Y.-H. Liang, and J. Zhao
Effect of Modified C-Reactive Protein on Complement Activation: A Possible Complement Regulatory Role of Modified or Monomeric C-Reactive Protein in Atherosclerotic Lesions
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 935 - 941.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
I. Ciubotaru, L. A. Potempa, and R. C. Wander
Production of Modified C-Reactive Protein in U937-Derived Macrophages
Experimental Biology and Medicine, November 1, 2005; 230(10): 762 - 770.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. T.H. Yeh
A New Perspective on the Biology of C-Reactive Protein
Circ. Res., September 30, 2005; 97(7): 609 - 611.
[Full Text] [PDF]


Home page
Circ. Res.Home page
T. Khreiss, L. Jozsef, L. A. Potempa, and J. G. Filep
Loss of Pentameric Symmetry in C-Reactive Protein Induces Interleukin-8 Secretion Through Peroxynitrite Signaling in Human Neutrophils
Circ. Res., September 30, 2005; 97(7): 690 - 697.
[Abstract] [Full Text] [PDF]


Home page
JAOA: Journal of the American Osteopathic AssociationHome page
M. B. Clearfield
C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular Disease
J Am Osteopath Assoc, September 1, 2005; 105(9): 409 - 416.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. B. Schwedler, K. Amann, K. Wernicke, A. Krebs, M. Nauck, C. Wanner, L. A. Potempa, and J. Galle
Native C-Reactive Protein Increases Whereas Modified C-Reactive Protein Reduces Atherosclerosis in Apolipoprotein E-Knockout Mice
Circulation, August 16, 2005; 112(7): 1016 - 1023.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. J. van Dijk, N. D. Prins, S. E. Vermeer, H. A. Vrooman, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler
C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study
Circulation, August 9, 2005; 112(6): 900 - 905.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. Ikonomidis, J. Lekakis, I. Revela, F. Andreotti, and P. Nihoyannopoulos
Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease
Eur. Heart J., August 2, 2005; 26(16): 1618 - 1624.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Liu, S. Wang, A. Deb, K. A. Nath, Z. S. Katusic, J. P. McConnell, and N. M. Caplice
Proapoptotic, Antimigratory, Antiproliferative, and Antiangiogenic Effects of Commercial C-Reactive Protein on Various Human Endothelial Cell Types In Vitro: Implications of Contaminating Presence of Sodium Azide in Commercial Preparation
Circ. Res., July 22, 2005; 97(2): 135 - 143.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. E. Taylor, J. C. Giddings, and C. W. van den Berg
C-Reactive Protein-Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and Lipopolysaccharide
Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1225 - 1230.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
K de Leeuw, J-S Sanders, C Stegeman, A Smit, C G Kallenberg, and M Bijl
Accelerated atherosclerosis in patients with Wegener's granulomatosis
Ann Rheum Dis, May 1, 2005; 64(5): 753 - 759.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Wang, X. Zhu, Q. Xu, X. Ding, Y. E. Chen, and Q. Song
Effect of C-reactive protein on gene expression in vascular endothelial cells
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1539 - H1545.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Black, I. Kushner, and D. Samols
C-reactive Protein
J. Biol. Chem., November 19, 2004; 279(47): 48487 - 48490.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Khreiss, L. Jozsef, L. A. Potempa, and J. G. Filep
Opposing Effects of C-Reactive Protein Isoforms on Shear-Induced Neutrophil-Platelet Adhesion and Neutrophil Aggregation in Whole Blood
Circulation, October 26, 2004; 110(17): 2713 - 2720.
[Abstract] [Full Text] [PDF]


Home page
JAOA: Journal of the American Osteopathic AssociationHome page
R. J. Chilton
Pathophysiology of Coronary Heart Disease: A Brief Review
J Am Osteopath Assoc, September 1, 2004; 104(9_suppl): 5S - 8S.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Verma, P. E. Szmitko, and E. T.H. Yeh
C-Reactive Protein: Structure Affects Function
Circulation, April 27, 2004; 109(16): 1914 - 1917.
[Full Text] [PDF]